ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in ImageneBio, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +10 vs. Q3 2021
- Shares held
- 27.4M
- +6.51M (+31.2%) vs. Q3 2021
- Total value
- $343.6M
- +$71.8M (+26.4%) vs. Q3 2021
- New holders
- 13
- 25 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 113 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 105 | $1.00K | 0.00% | +105 | New |
| Tower Research Capital LLC (TRC) | 1,755 | $22.0K | 0.00% | +1,009+135.3% | Added |
| STRS Ohio | 2,100 | $26.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 2,142 | $27.0K | 0.00% | +1,431+201.3% | Added |
| Legal & General Group Plc | 2,273 | $29.0K | 0.00% | +1,341+143.9% | Added |
| Baystate Wealth Management LLC | 2,999 | $38.0K | 0.00% | +2,999 | New |
| Royal Bank of Canada | 5,747 | $72.0K | 0.00% | +4,252+284.4% | Added |
| Metropolitan Life Insurance Co | 8,698 | $109.1K | 0.00% | +8,698 | New |
| Citigroup Inc | 9,057 | $114.0K | 0.00% | +7,692+563.5% | Added |
| SG Americas Securities, LLC | 9,353 | $117.0K | 0.00% | +9,353 | New |
| ProShare Advisors LLC | 11,111 | $138.0K | 0.00% | +11,111 | New |
| MetLife Investment Management | 11,742 | $147.2K | 0.00% | +11,742 | New |
| Morgan Stanley | 12,140 | $153.0K | 0.00% | +8,909+275.7% | Added |
| Goldman Sachs Group Inc | 12,864 | $161.0K | 0.00% | +12,864 | New |
| New York State Common Retirement Fund | 13,684 | $172.0K | 0.00% | +5,895+75.7% | Added |
| JPMorgan Chase & Co | 13,690 | $172.0K | 0.00% | +9,710+244.0% | Added |
| Manufacturers Life Insurance Company, The | 13,936 | $175.0K | 0.00% | +13,936 | New |
| Susquehanna International Group, LLP | 14,567 | $183.0K | 0.00% | +14,567 | New |
| Wells Fargo & Company | 14,607 | $184.0K | 0.00% | +385+2.7% | Added |
| American International Group, Inc. | 14,725 | $185.0K | 0.00% | +9,038+158.9% | Added |
| California State Teachers Retirement System | 15,147 | $190.0K | 0.00% | +10,301+212.6% | Added |
| Deutsche Bank AG | 16,838 | $211.0K | 0.00% | +10,864+181.9% | Added |
| Millennium Management LLC | 17,333 | $217.0K | 0.00% | +17,333 | New |
| Bank of America Corp | 24,642 | $309.0K | 0.00% | +13,720+125.6% | Added |
| Rhumbline Advisers | 28,102 | $352.0K | 0.00% | +28,102 | New |
| Qube Research & Technologies Ltd | 42,788 | $537.0K | 0.00% | +42,788 | New |
| Charles Schwab Investment Management Inc | 63,534 | $797.0K | 0.00% | +38,230+151.1% | Added |
| Bank of New York Mellon Corp | 77,862 | $977.0K | 0.00% | +54,988+240.4% | Added |
| Nuveen Asset Management, LLC | 72,793 | $997.0K | 0.00% | +39,709+120.0% | Added |
| Victory Capital Management Inc | 112,330 | $1.41M | 0.00% | +20,790+22.7% | Added |
| Ensign Peak Advisors, Inc | 127,810 | $1.60M | 0.00% | +27,810+27.8% | Added |
| Northern Trust Corp | 208,065 | $2.61M | 0.00% | +116,308+126.8% | Added |
| Geode Capital Management, LLC | 284,454 | $3.57M | 0.00% | +89,993+46.3% | Added |
| HealthCor Management, L.P. | 287,621 | $3.61M | 0.20% | −52,330−15.4% | Reduced |
| Logos Global Management LP | 299,853 | $3.76M | 0.39% | 00.0% | Unchanged |
| State Street Corp | 340,614 | $4.27M | 0.00% | +208,146+157.1% | Added |
| Ra Capital Management, L.P. | 750,000 | $9.40M | 0.17% | 00.0% | Unchanged |
| Vanguard Group Inc | 782,394 | $9.81M | 0.00% | +161,708+26.1% | Added |
| CHI Advisors LLC | 814,756 | $10.2M | 3.39% | +499,756+158.7% | Added |
| Farallon Capital Management, L.L.C. | 1,081,309 | $13.6M | 0.08% | −36,040−3.2% | Reduced |
| BlackRock Inc. | 1,363,877 | $17.1M | 0.00% | +879,946+181.8% | Added |
| Artal Group S.A. | 1,549,513 | $19.4M | 0.57% | 00.0% | Unchanged |
| BVF Inc | 1,798,371 | $22.6M | 0.82% | −33,700−1.8% | Reduced |
| Citadel Advisors LLC | 2,128,148 | $26.7M | 0.03% | +1,0630.0% | Added |
| Omega Fund Management, LLC | 2,249,123 | $28.2M | 3.99% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,933,941 | $36.8M | 0.48% | 00.0% | Unchanged |
| FMR LLC | 4,723,687 | $59.2M | 0.00% | −307,453−6.1% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $62.9M | 5.78% | +5,018,178 | New |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −275,000−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −199,781−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −85−100.0% | Sold out |